X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (134) 134
Publication (18) 18
Patent (12) 12
Book Review (2) 2
Conference Proceeding (2) 2
Newspaper Article (2) 2
Dissertation (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology & hepatology (47) 47
humans (44) 44
index medicus (38) 38
female (27) 27
male (24) 24
adult (23) 23
gastroenterology and hepatology (22) 22
inflammatory bowel disease (22) 22
ulcerative colitis (22) 22
middle aged (21) 21
aged (20) 20
adolescent (16) 16
surgery (15) 15
clinical medicine (14) 14
crohn's disease (14) 14
inflammatory-bowel-disease (14) 14
management (14) 14
klinisk medicin (13) 13
medical and health sciences (13) 13
medicin och hälsovetenskap (13) 13
physics (13) 13
young adult (13) 13
analysis (12) 12
calculating (12) 12
computing (12) 12
counting (12) 12
electric digital data processing (12) 12
gastroenterologi (11) 11
infliximab (11) 11
patients (11) 11
care and treatment (10) 10
quality-of-life (10) 10
crohns-disease (9) 9
gastroenterology (9) 9
treatment outcome (9) 9
aged, 80 and over (8) 8
colitis, ulcerative - drug therapy (8) 8
follow-up studies (8) 8
ibd (8) 8
inflammatory bowel diseases (8) 8
medical research (8) 8
medicine, experimental (8) 8
quality of life (8) 8
retrospective studies (8) 8
therapy (8) 8
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (7) 7
diagnosis (7) 7
oncology (7) 7
prognosis (7) 7
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (7) 7
abridged index medicus (6) 6
azathioprine (6) 6
medicine & public health (6) 6
prospective studies (6) 6
severity of illness index (6) 6
time factors (6) 6
ulcerative-colitis (6) 6
anti-inflammatory agents, non-steroidal - therapeutic use (5) 5
crohn disease - drug therapy (5) 5
endoscopy (5) 5
epidemiology (5) 5
europe (5) 5
follow-up (5) 5
health aspects (5) 5
inflammatory bowel diseases - therapy (5) 5
remission induction (5) 5
research (5) 5
risk (5) 5
risk factors (5) 5
treatment (5) 5
adalimumab (4) 4
biopsy (4) 4
child (4) 4
children (4) 4
consensus (4) 4
crohn disease - complications (4) 4
crohn’s disease (4) 4
dosage and administration (4) 4
drug therapy (4) 4
fistula (4) 4
general tagging of cross-sectional technologies spanning over several sections of the ipc (4) 4
general tagging of new technological developments (4) 4
guidelines (4) 4
hematology, oncology and palliative medicine (4) 4
inflammatory bowel diseases - drug therapy (4) 4
mesalamine - therapeutic use (4) 4
monoclonal antibodies (4) 4
patient outcomes (4) 4
physics, multidisciplinary (4) 4
population-based cohort (4) 4
quantum physics (4) 4
remission (4) 4
rescue therapy (4) 4
safety (4) 4
technical subjects covered by former uspc (4) 4
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (4) 4
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (4) 4
tumor necrosis factor-α (4) 4
anti-tnf (3) 3
anti-tnf therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


GastroHep, ISSN 1478-1239, 05/2019, Volume 1, Issue 3, pp. 91 - 92
Journal Article
Gut, ISSN 0017-5749, 06/2019, Volume 68, Issue Suppl 2, p. A65
BackgroundWhile infliximab is used as rescue therapy for steroid refractory acute severe colitis (ASUC), between 30 and 40% of patients do not respond and... 
Journal Article
Gut, ISSN 0017-5749, 06/2019, Volume 68, Issue Suppl 2, p. A92
IntroductionLack of comparative trial data on dosing regimens of infliximab rescue therapy in acute severe ulcerative colitis (ASUC) has resulted in variable... 
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 11/2019, Volume 50, Issue 9, pp. 1061 - 1062
LINKED CONTENTThis article is linked to Sebastian et al and Chedid and Kane papers. To view these articles, visit https://doi.org/10.1111/apt.15456 and... 
Infliximab | Monoclonal antibodies | Tumor necrosis factor-α
Journal Article
Therapeutic Advances in Gastroenterology, ISSN 1756-283X, 01/2019, Volume 12, p. 1756284818817293
Clinicians involved in the treatment of inflammatory bowel disease (IBD) increasingly come across patients with current or previous history of malignancies.... 
Inflammatory bowel disease | treatment | risks | therapy | Cancer | RHEUMATOID-ARTHRITIS | ANTI-TNF | CELL CARCINOMA | FACTOR-ALPHA | FACTOR THERAPY | TUMOR-NECROSIS-FACTOR | NONMELANOMA SKIN-CANCER | INCREASED RISK | GASTROENTEROLOGY & HEPATOLOGY | AND/OR LYMPHOMA | REFRACTORY IBD
Journal Article
Journal Article
Journal Article
Gut, ISSN 0017-5749, 06/2018, Volume 67, Issue Suppl 1, p. A74
IntroductionTherapeutic Drug and antibody monitoring (TDM) is now an established strategy to manage patients with Inflammatory Bowel disease being treated with... 
Journal Article
Gut, ISSN 0017-5749, 06/2017, Volume 66, Issue 6, pp. 988 - 1000
Journal Article